Arcellx (ACLX) Operating Expenses (2021 - 2025)
Arcellx's (ACLX) quarterly Operating Expenses came in at $65.3 million in Q4 2025, down 4.5% year-on-year from $68.4 million in Q4 2024, and down 2.08% quarter-over-quarter from $66.7 million in Q3 2025.
Arcellx (ACLX) Operating Expenses (2021 - 2025) Analysis & Trends
Arcellx's Operating Expenses history runs 5 years deep, the most recent figure standing at $65.3 million for Q4 2025.
- On a quarterly basis, Operating Expenses fell 4.5% year-over-year to $65.3 million in Q4 2025; TTM through Dec 2025 was $275.4 million, a 12.16% increase from a year earlier, with the FY2025 full-year figure at $275.4 million, up 12.16% from the prior year.
- Operating Expenses declined to $65.3 million in Q4 2025 per ACLX's latest filing, from $66.7 million in the prior quarter.
- Across five years, Operating Expenses topped out at $93.9 million in Q3 2022 and bottomed at $11.3 million in Q1 2021.
- The 5-year median for Operating Expenses is $51.7 million (2023), against an average of $48.9 million.
- Across the five-year window, Operating Expenses surged 448.66% in 2022 and plunged 36.28% in 2023, its largest moves.
- Year by year, Operating Expenses stood at $20.7 million in 2021, then surged by 93.27% to $40.0 million in 2022, then grew by 20.36% to $48.1 million in 2023, then soared by 42.1% to $68.4 million in 2024, then decreased by 4.5% to $65.3 million in 2025.
- Per Business Quant, the three latest ACLX Operating Expenses figures stand at $65.3 million (Q4 2025), $66.7 million (Q3 2025), and $66.3 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 65.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.34 Mn |
| Sep 30, 2025 | 66.73 Mn |
| Jun 30, 2025 | 66.28 Mn |
| Mar 31, 2025 | 77.03 Mn |
| Dec 31, 2024 | 68.42 Mn |
| Sep 30, 2024 | 59.65 Mn |
| Jun 30, 2024 | 62.38 Mn |
| Mar 31, 2024 | 55.07 Mn |
| Dec 31, 2023 | 48.15 Mn |
| Sep 30, 2023 | 59.82 Mn |
| Jun 30, 2023 | 43.86 Mn |
| Mar 31, 2023 | 48.37 Mn |
| Dec 31, 2022 | 40.00 Mn |
| Sep 30, 2022 | 93.88 Mn |
| Jun 30, 2022 | 31.29 Mn |
| Mar 31, 2022 | 26.09 Mn |
| Dec 31, 2021 | 20.70 Mn |
| Sep 30, 2021 | 17.11 Mn |
| Jun 30, 2021 | 15.93 Mn |
| Mar 31, 2021 | 11.28 Mn |